Pfizer Wins Corporate Citizenship Award For Global Health Partnerships Program

PfizerPfizer Inc. has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program. The "Citizens" Awards honor excellence in corporate citizenship and civic leadership for initiatives in both the United States and across the world.

"The essence of a successful corporate social responsibility program is when it becomes a model that other companies want to imitate," said U.S. Chamber of Commerce Business Civic Leadership Center Founder and Executive Director Stephen Jordan. "This award for Pfizer’s Global Health Partnership validates what many companies have known for a long time. This is a great program."

Pfizer's Global Health Partnerships (GHP) combines the philanthropic and in-kind resources of the Pfizer Foundation and Pfizer Inc. to combat noncommunicable diseases (NCDs) by strengthening healthcare systems and infrastructure to support cancer and tobacco control efforts. The fight against NCDs and their risk factors, such as tobacco use, has largely been neglected in overseas development aid to low and middle income countries. Only 2% of the more than $44 billion in aid has been devoted to fighting these diseases in the developing world. Pfizer and the Pfizer Foundation recognize this gap and through GHP have invested $47 million over four years in promising cancer and tobacco-control partner organizations operating in 46 countries.

"Through Pfizer's Global Health Partnerships, Pfizer supports the growth of promising cancer- and tobacco-control organizations united by the shared mission of accelerating the pace of progress in the fight against cancer," said Caroline Roan, vice president, Corporate Responsibility and president of the Pfizer Foundation. "Pfizer is proud to be awarded Best International Ambassador Award and for its commitment to foster a culture of results-oriented discovery and innovation."

The 2011 Business Civic Leadership Awards was presented on Thursday, November 17th, at the Corporate Citizenship Awards gala in Washington, DC.

About the Business Civic Leadership Center (BCLC)
BCLC is the U.S. Chamber's resource and voice for businesses' social and philanthropic interests. Its mission is to advance the positive role of business in society. The U.S. Chamber of Commerce is the world’s largest business federation representing the interests of more than 3 million businesses of all sizes, sectors, and regions, as well as state and local chambers and industry associations.

Pfizer Inc.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Most Popular Now

Top 20 breaking World Pharma News of 2017

We are proud to announce the top 20 most popular breaking World Pharma News from 2017. Have a wonderful 2018 new(s) year filled with health, happiness, and spectacular su...

Novartis advances head-to-head superiority trials …

Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondyl...

Diabetes drug 'significantly reverses memory loss…

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action...

Sandoz regulatory submission for proposed biosimil…

Sandoz, a Novartis division and the global leader in biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics Licen...

Zika remains a research and public health challeng…

Since 2016, when Zika was declared by the World Health Organization as a public health emergency of international concern, the virus has become established in more than 8...

Try exercise to improve memory, thinking

For patients with mild cognitive impairment, don't be surprised if your health care provider prescribes exercise rather than medication. A new guideline for medical pract...

New research paper shows that AstraZeneca has achi…

In a research paper published today by Nature Reviews Drug Discovery(1), AstraZeneca's IMED Biotech Unit documents a more than four-fold improvement in R&D productivity f...

Dirt-dwelling microbe produces potential anti-mela…

A type of soil-dwelling bacterium produces molecules that induce death in melanoma cells, research at Oregon State University shows. The molecule is a secondary metabolit...

Novartis Kisqali® received FDA Breakthrough Therap…

Novartis today announced Kisqali® (ribociclib) received US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based treatment of pr...

FDA approves first treatment for breast cancer wit…

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast can...

Berry gives boost to cervical cancer therapy

According to the Centers for Disease Control and Prevention, approximately 12,000 women in the United States are diagnosed with cervical cancer each year. One of the most...

Novartis appoints Elizabeth Barrett as Oncology He…

Novartis announced today that Elizabeth (Liz) Barrett, currently Global President Oncology at Pfizer, Inc., has been appointed CEO Novartis Oncology and a member of the E...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]